Nifty

:

22828.55

Sensex

:

75157.26

429.40 (1.92%)
1310.11 (1.77%)

Login

Nifty
Sensex

:
:

22828.55
75157.26

429.40 (1.92%)
1310.11 (1.77%)

Zota Health Care Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: Not Listed | NSE: ZOTA

Watchlist

NSE BSE

1002.70

06-Feb-2025

Open
High
Low
Previous Close

984.00
1029.15
984.00
995.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

84031
851.42
1078.00
440.10

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,251.43
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,251.26
0.13%
11.41

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.42
13.66
11.21

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-2.94
10.88
-12.14

PAT CAGR (%)

10 Years
5 Years
3 Years

-2.31
4.14
-31.64

P:E (Median)

8 Years
5 Years
3 Years

-
64.12
-

P:BV (Average)

8 Years
5 Years
3 Years

-
9.51
11.05

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
217.35
302.72

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 68.13 42.84 59.03% 59.01 41.15 43.40% 52.20 35.25 48.09% 47.35 36.26 30.58%
Expenses 66.82 40.71 64.14% 55.77 38.05 46.57% 49.26 34.64 42.21% 46.96 35.68 31.61%
EBITDA 1.31 2.13 -38.50% 3.24 3.10 4.52% 2.95 0.61 383.61% 0.39 0.57 -31.58%
EBIDTM 1.92% 4.97% 5.50% 7.53% 5.65% 1.74% 0.81% 1.58%
Other Income 1.69 0.38 344.74% 0.97 0.63 53.97% 0.47 0.36 30.56% 0.69 0.24 187.50%
Interest 0.04 0.00 0 0.52 0.25 108.00% 0.42 0.05 740.00% 0.06 0.01 500.00%
Depreciation 0.82 0.83 -1.20% 0.73 0.77 -5.19% 0.68 0.55 23.64% 0.86 0.67 28.36%
PBT 2.14 1.67 28.14% 2.96 2.71 9.23% 2.32 0.37 527.03% 0.16 0.67 -76.12%
Tax 0.06 0.51 -88.24% 0.61 0.92 -33.70% 0.74 0.16 362.50% -0.07 0.02 -
PAT 2.08 1.16 79.31% 2.35 1.79 31.28% 1.58 0.21 652.38% 0.22 0.65 -66.15%
PATM 3.05% 2.70% 3.99% 4.34% 3.03% 0.60% 0.47% 1.80%
EPS 0.75 0.42 78.57% 0.85 0.65 30.77% 0.57 0.08 612.50% 0.08 0.24 -66.67%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 72.12 46.93 53.68% 67.28 45.27 48.62% 56.30 38.65 45.67% 49.64 36.85 34.71%
Expenses 78.19 43.60 79.33% 68.15 40.85 66.83% 57.56 37.37 54.03% 51.12 35.82 42.71%
EBITDA -6.07 3.33 - -0.87 4.43 - -1.26 1.28 - -1.48 1.03 -
EBIDTM -8.42% 7.10% -1.29% 9.78% -2.24% 3.31% -2.99% 2.80%
Other Income 0.51 0.15 240.00% 0.54 0.40 35.00% 0.02 0.15 -86.67% 0.46 0.03 1,433.33%
Interest 1.57 1.14 37.72% 2.85 1.14 150.00% 2.90 0.83 249.40% 1.68 0.81 107.41%
Depreciation 11.35 5.08 123.43% 9.51 4.80 98.12% 8.02 3.41 135.19% 6.80 3.88 75.26%
PBT -18.48 -2.73 - -12.69 -1.11 - -12.16 -2.81 - -9.51 -3.09 -
Tax 0.46 0.21 119.05% -0.51 0.54 - 0.56 0.03 1,766.67% -2.59 -0.46 -
PAT -18.94 -2.94 - -12.18 -1.65 - -12.72 -2.84 - -6.92 -2.63 -
PATM -26.27% -6.26% -18.10% -3.65% -22.60% -7.35% -13.94% -7.15%
EPS -6.78 -1.14 - -4.42 -0.64 - -4.80 -1.13 - -2.68 -1.05 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 226.69 166.52 138.32 131.51 106.82 95.11 85.63 77.84 71.58 64.73 56.46 Net Sales Growth 45.78% 20.39% 5.18% 23.11% 12.31% 11.07% 10.01% 8.75% 10.58% 14.65% Cost Of Goods Sold 136.02 104.45 88.25 87.54 73.34 66.30 57.01 51.04 45.15 42.11 36.80 Gross Profit 90.67 62.07 50.07 43.97 33.47 28.81 28.62 26.81 26.43 22.62 19.66 GP Margin 40.00% 37.27% 36.20% 33.43% 31.33% 30.29% 33.42% 34.44% 36.92% 34.95% 34.82% Total Expenditure 218.81 160.21 130.98 116.52 106.19 90.58 77.88 67.02 61.54 55.17 47.96 Power & Fuel Cost - 3.47 4.04 0.90 0.76 0.68 0.61 0.44 0.33 0.37 0.30 % Of Sales - 2.08% 2.92% 0.68% 0.71% 0.71% 0.71% 0.57% 0.46% 0.57% 0.53% Employee Cost - 18.76 10.68 9.10 8.56 9.59 8.02 6.28 5.79 4.79 3.93 % Of Sales - 11.27% 7.72% 6.92% 8.01% 10.08% 9.37% 8.07% 8.09% 7.40% 6.96% Manufacturing Exp. - 2.63 1.70 2.35 1.96 1.79 1.83 2.02 2.24 1.90 1.65 % Of Sales - 1.58% 1.23% 1.79% 1.83% 1.88% 2.14% 2.60% 3.13% 2.94% 2.92% General & Admin Exp. - 6.36 4.87 7.55 6.78 6.07 5.54 3.47 3.00 2.46 2.38 % Of Sales - 3.82% 3.52% 5.74% 6.35% 6.38% 6.47% 4.46% 4.19% 3.80% 4.22% Selling & Distn. Exp. - 24.42 21.27 9.01 14.62 5.88 4.46 3.46 4.82 3.45 2.79 % Of Sales - 14.66% 15.38% 6.85% 13.69% 6.18% 5.21% 4.45% 6.73% 5.33% 4.94% Miscellaneous Exp. - 0.12 0.16 0.07 0.16 0.28 0.41 0.32 0.21 0.09 2.79 % Of Sales - 0.07% 0.12% 0.05% 0.15% 0.29% 0.48% 0.41% 0.29% 0.14% 0.19% EBITDA 7.89 6.31 7.34 14.99 0.63 4.53 7.75 10.82 10.04 9.56 8.50 EBITDA Margin 3.48% 3.79% 5.31% 11.40% 0.59% 4.76% 9.05% 13.90% 14.03% 14.77% 15.05% Other Income 3.82 1.96 3.23 2.00 1.30 1.52 1.54 1.59 0.06 0.08 0.01 Interest 1.04 0.36 0.06 0.07 0.11 0.07 0.04 0.12 0.68 0.68 0.66 Depreciation 3.09 3.01 2.42 2.73 3.17 2.10 1.39 0.94 1.05 1.23 1.51 PBT 7.58 4.91 8.09 14.19 -1.34 3.88 7.86 11.36 8.36 7.72 6.34 Tax 1.34 1.53 2.03 3.61 -0.15 1.12 2.31 4.07 2.82 2.61 2.08 Tax Rate 17.68% 31.16% 23.52% 25.44% 48.39% 28.87% 29.39% 35.89% 33.73% 33.81% 32.81% PAT 6.23 3.38 6.59 10.58 -0.16 2.76 5.55 7.27 5.54 5.11 4.27 PAT before Minority Interest 6.23 3.38 6.59 10.58 -0.16 2.76 5.55 7.27 5.54 5.11 4.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.75% 2.03% 4.76% 8.05% -0.15% 2.90% 6.48% 9.34% 7.74% 7.89% 7.56% PAT Growth 63.52% -48.71% -37.71% - - -50.27% -23.66% 31.23% 8.41% 19.67% EPS 2.26 1.22 2.39 3.83 -0.06 1.00 2.01 2.63 2.01 1.85 1.55

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 245.34 180.43 139.91 131.17 106.77 95.11 85.63 Net Sales Growth 46.30% 28.96% 6.66% 22.85% 12.26% 11.07% Cost Of Goods Sold 112.22 96.70 83.27 86.62 73.28 66.30 57.01 Gross Profit 133.12 83.72 56.64 44.55 33.48 28.81 28.62 GP Margin 54.26% 46.40% 40.48% 33.96% 31.36% 30.29% 33.42% Total Expenditure 255.02 172.87 133.25 116.73 106.19 90.60 77.89 Power & Fuel Cost - 2.31 1.35 0.94 0.77 0.68 0.61 % Of Sales - 1.28% 0.96% 0.72% 0.72% 0.71% 0.71% Employee Cost - 29.24 12.15 9.48 8.56 9.59 8.02 % Of Sales - 16.21% 8.68% 7.23% 8.02% 10.08% 9.37% Manufacturing Exp. - 2.69 1.72 2.35 1.96 1.79 1.83 % Of Sales - 1.49% 1.23% 1.79% 1.84% 1.88% 2.14% General & Admin Exp. - 11.74 8.21 7.81 6.83 6.24 5.54 % Of Sales - 6.51% 5.87% 5.95% 6.40% 6.56% 6.47% Selling & Distn. Exp. - 30.08 26.38 9.47 14.62 5.83 4.46 % Of Sales - 16.67% 18.85% 7.22% 13.69% 6.13% 5.21% Miscellaneous Exp. - 0.12 0.16 0.07 0.16 0.18 0.41 % Of Sales - 0.07% 0.11% 0.05% 0.15% 0.19% 0.48% EBITDA -9.68 7.56 6.66 14.44 0.58 4.51 7.74 EBITDA Margin -3.95% 4.19% 4.76% 11.01% 0.54% 4.74% 9.04% Other Income 1.53 1.16 2.62 1.99 1.31 1.52 1.54 Interest 9.00 4.79 2.56 0.32 0.11 0.07 0.04 Depreciation 35.68 20.09 11.96 3.67 3.17 2.10 1.39 PBT -52.84 -16.16 -5.23 12.43 -1.39 3.86 7.86 Tax -2.08 -1.82 1.08 3.53 -0.16 1.12 2.31 Tax Rate 3.94% 11.26% -23.03% 28.40% 44.44% 29.02% 29.39% PAT -50.76 -14.35 -5.77 8.91 -0.21 2.74 5.55 PAT before Minority Interest -50.42 -14.35 -5.77 8.91 -0.21 2.74 5.55 Minority Interest 0.34 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -20.69% -7.95% -4.12% 6.79% -0.20% 2.88% 6.48% PAT Growth 0.00% - - - - -50.63% EPS -18.39 -5.20 -2.09 3.23 -0.08 0.99 2.01

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 121.78 94.46 91.37 66.37 68.85 68.93 69.78 26.98 21.44 18.32 Share Capital 25.85 25.16 25.16 24.56 24.56 17.54 17.54 14.36 14.36 14.36 Total Reserves 95.93 69.30 66.21 41.81 44.29 51.39 52.23 12.62 7.08 3.96 Non-Current Liabilities 1.15 0.85 0.96 0.95 1.05 0.87 0.65 3.03 2.73 2.46 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.22 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.46 2.23 2.00 Long Term Provisions 1.18 0.94 1.03 0.94 0.87 0.76 0.49 0.45 0.34 0.00 Current Liabilities 50.33 29.24 32.88 18.20 18.59 19.82 21.37 23.79 19.88 19.60 Trade Payables 30.84 24.82 18.32 15.59 14.99 16.17 16.47 18.36 14.60 11.71 Other Current Liabilities 1.31 0.95 10.00 1.67 1.64 0.52 0.31 0.36 0.40 0.53 Short Term Borrowings 14.68 0.00 0.00 0.00 0.00 0.00 0.00 1.64 0.00 3.02 Short Term Provisions 3.50 3.47 4.56 0.94 1.96 3.12 4.59 3.44 4.88 4.33 Total Liabilities 173.26 124.55 125.21 85.52 88.49 89.62 91.80 53.80 44.05 40.38 Net Block 11.94 11.45 12.56 13.99 15.41 9.78 9.56 6.72 7.23 8.23 Gross Block 35.95 32.45 31.14 29.84 28.09 20.36 18.76 14.98 14.45 14.24 Accumulated Depreciation 24.01 21.00 18.58 15.85 12.68 10.59 9.19 8.26 7.23 6.01 Non Current Assets 44.26 36.75 50.01 24.39 29.73 27.24 36.05 9.33 8.56 8.42 Capital Work in Progress 4.80 3.10 0.00 0.04 0.00 1.55 0.04 2.50 1.13 0.00 Non Current Investment 6.77 9.54 34.84 9.99 14.03 15.62 26.15 0.00 0.09 0.08 Long Term Loans & Adv. 20.75 12.67 2.61 0.37 0.29 0.29 0.31 0.11 0.11 0.11 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 128.99 87.80 75.21 61.13 58.76 62.37 55.74 44.48 35.50 31.96 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 40.06 35.83 27.98 28.13 25.34 32.51 24.28 23.91 16.33 17.62 Sundry Debtors 73.71 43.56 38.32 28.84 29.14 22.10 22.93 17.08 15.78 11.69 Cash & Bank 0.14 0.88 2.20 1.33 0.73 1.69 2.46 0.14 0.76 0.16 Other Current Assets 15.08 0.97 0.04 0.64 3.55 6.07 6.07 3.35 2.63 2.49 Short Term Loans & Adv. 13.99 6.56 6.67 2.20 3.27 3.54 5.63 3.08 2.60 2.39 Net Current Assets 78.67 58.56 42.33 42.94 40.17 42.56 34.37 20.69 15.61 12.36 Total Assets 173.25 124.55 125.22 85.52 88.49 89.61 91.79 53.81 44.06 40.38

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 89.98 80.36 89.63 66.30 68.83 68.93 Share Capital 25.85 25.16 25.16 24.56 24.56 17.54 Total Reserves 64.13 55.20 64.47 41.74 44.27 51.38 Non-Current Liabilities 60.26 36.12 13.35 0.95 1.05 0.87 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.50 0.98 1.04 0.94 0.87 0.76 Current Liabilities 73.68 40.52 35.96 18.23 18.60 19.81 Trade Payables 33.61 26.46 18.70 15.60 14.99 16.17 Other Current Liabilities 19.06 10.32 12.63 1.67 1.64 0.52 Short Term Borrowings 14.68 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 6.34 3.74 4.63 0.96 1.96 3.13 Total Liabilities 223.92 157.00 138.94 85.48 88.48 89.61 Net Block 102.70 62.08 29.10 14.08 15.41 9.78 Gross Block 145.79 85.08 47.91 29.93 28.09 20.36 Accumulated Depreciation 43.09 23.00 18.81 15.85 12.68 10.59 Non Current Assets 112.31 72.82 62.03 24.27 29.61 27.23 Capital Work in Progress 4.80 3.10 0.00 0.04 0.00 1.55 Non Current Investment 4.70 7.53 32.84 9.89 13.92 15.61 Long Term Loans & Adv. 0.11 0.11 0.09 0.27 0.28 0.29 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 111.62 84.17 76.90 61.21 58.86 62.37 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 53.77 41.79 28.95 28.18 25.34 32.51 Sundry Debtors 27.24 27.83 36.37 28.77 29.14 22.10 Cash & Bank 1.00 1.12 2.30 1.35 0.83 1.69 Other Current Assets 29.61 2.76 0.94 0.66 3.55 6.07 Short Term Loans & Adv. 21.84 10.68 8.35 2.25 3.27 3.54 Net Current Assets 37.93 43.65 40.94 42.98 40.27 42.56 Total Assets 223.93 156.99 138.93 85.48 88.47 89.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -30.14 -10.29 13.66 -0.84 5.55 -3.24 -4.43 3.35 4.56 4.65 PBT 4.91 8.62 14.19 -0.32 3.88 7.86 11.34 8.36 7.72 6.34 Adjustment 1.54 0.51 1.46 1.45 1.06 0.01 -0.41 1.71 1.85 2.12 Changes in Working Capital -35.08 -17.29 1.75 -1.91 1.71 -8.78 -11.32 -3.85 -2.32 -1.60 Cash after chg. in Working capital -28.63 -8.15 17.40 -0.78 6.65 -0.92 -0.39 6.22 7.25 6.86 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.52 -2.14 -3.73 -0.06 -1.10 -2.32 -4.04 -2.87 -2.69 -2.21 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -8.67 12.76 -27.06 3.91 -3.54 8.83 -26.19 -1.81 -1.35 -0.70 Net Fixed Assets -5.20 -4.41 -1.26 -1.79 -6.18 -3.11 -1.32 -1.90 -1.34 -0.71 Net Investments 2.77 25.30 -24.85 4.04 1.59 10.53 -26.15 0.09 -0.01 0.00 Others -6.24 -8.13 -0.95 1.66 1.05 1.41 1.28 0.00 0.00 0.01 Cash from Financing Activity 38.08 -3.79 14.27 -2.47 -2.97 -6.35 32.94 -2.16 -2.62 -3.93 Net Cash Inflow / Outflow -0.73 -1.32 0.87 0.60 -0.97 -0.77 2.33 -0.62 0.59 0.02 Opening Cash & Equivalents 0.88 2.20 1.33 0.73 1.69 2.46 0.14 0.76 0.16 0.14 Closing Cash & Equivalent 0.14 0.88 2.20 1.33 0.73 1.69 2.46 0.14 0.76 0.16

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity -5.98 -2.01 13.33 -0.89 5.56 -3.25 PBT -16.16 -4.69 12.43 -0.37 3.86 7.86 Adjustment 23.69 13.12 2.66 1.45 1.06 0.01 Changes in Working Capital -11.98 -8.29 1.97 -1.91 1.73 -8.79 Cash after chg. in Working capital -4.45 0.13 17.07 -0.83 6.65 -0.93 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.53 -2.14 -3.73 -0.06 -1.10 -2.32 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -12.90 14.70 -26.65 3.82 -3.54 8.83 Net Fixed Assets -5.20 -4.41 -1.26 -1.79 -6.18 Net Investments 2.77 25.30 -24.85 4.04 1.59 Others -10.47 -6.19 -0.54 1.57 1.05 Cash from Financing Activity 18.78 -13.88 14.27 -2.42 -2.87 -6.35 Net Cash Inflow / Outflow -0.11 -1.18 0.95 0.51 -0.86 -0.77 Opening Cash & Equivalents 1.12 2.30 1.35 0.83 1.69 2.46 Closing Cash & Equivalent 1.00 1.12 2.30 1.35 0.83 1.69

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 47.11 37.54 36.32 27.02 28.03 28.06 28.41 13.42 10.66 9.11 ROA 2.27% 5.28% 10.04% -0.19% 3.10% 6.12% 9.98% 11.32% 12.10% 11.34% ROE 3.13% 7.10% 13.41% -0.24% 4.01% 8.01% 15.02% 22.89% 25.70% 25.00% ROCE 4.57% 9.35% 18.09% -0.30% 5.73% 11.39% 22.73% 33.04% 35.60% 31.71% Fixed Asset Turnover 4.87 4.35 4.31 3.69 3.93 4.38 4.62 4.86 4.51 4.07 Receivable days 128.48 108.00 93.18 99.04 98.30 95.96 93.80 83.78 77.44 72.30 Inventory Days 83.15 84.17 77.85 91.33 111.01 121.05 112.98 102.60 95.73 97.45 Payable days 97.26 89.20 70.68 76.08 85.76 73.03 99.18 89.74 90.17 75.55 Cash Conversion Cycle 114.37 102.96 100.35 114.29 123.55 143.97 107.60 96.63 83.00 94.20 Total Debt/Equity 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.10 0.29 Interest Cover 14.45 137.22 194.87 -1.88 57.15 214.57 94.67 13.25 12.30 10.54

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 34.81 31.94 35.62 26.99 28.02 28.06 ROA -7.53% -3.90% 7.94% -0.24% 3.08% 6.19% ROE -16.85% -6.79% 11.43% -0.31% 3.98% 8.05% ROCE -12.30% -2.50% 16.36% -0.38% 5.71% 11.45% Fixed Asset Turnover 1.56 2.10 3.37 3.68 3.93 4.21 Receivable days 55.69 83.71 90.61 98.96 98.30 94.19 Inventory Days 96.62 92.24 79.46 91.46 111.01 138.59 Payable days 113.36 98.97 72.26 76.17 85.77 72.36 Cash Conversion Cycle 38.95 76.98 97.82 114.25 123.54 160.41 Total Debt/Equity 0.16 0.00 0.00 0.00 0.00 0.00 Interest Cover -2.38 -0.83 39.77 -2.33 56.64 214.47

Top Investors:

asha mukul agrawal

mukul mahavir agrawal

jainam broking limited

Annual Reports:

News Update:

Zota Health Care expands Davaindia network to 1,530 operational stores
17th Mar 2025, 14:30 PM

The Company has also launched its first three 24*7 pharmacy stores via COCO model in Bengaluru, Mumbai and Pune
Read More
Zota Health Care acquires further equity shares in DIHML
12th Mar 2025, 10:30 AM

Post to this acquisition DIHML continues to remain as the WOS of the Company
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback